Low-cost test could pick out breast cancer patients at increased risk of relapse
Testing women's response to hormone therapy for breast cancer given around the time of surgery could be a fast and cheap way of predicting how likely the disease is to come back, a major clinical trial has found.
Nov 3, 2020
0
53